Search

everythinglearnresearchcommunity

for

Search:↓

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Dutasteride and finasteride don't raise erectile dysfunction risk.

Cilostazol may help hair grow and could be a new treatment for hair loss.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Finasteride treatment makes the prostate look more like a healthy one.

Ultrasound shows 96% of young men with erectile dysfunction after using finasteride have abnormal penile tissue.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction, but the exact reasons are unclear.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Urologists prescribe newer medications more often than primary care physicians, who could benefit from more education on treatment options.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Low-intensity shock wave therapy is effective in treating erectile dysfunction in diabetic patients.

A new compound effectively inhibits human 5α-reductase 1.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

Taking sildenafil and finasteride together is safe and improves urinary and sexual symptoms in BPH patients.

Combination therapy is more effective for prostate volumes over 60 ml.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

5alpha-reductase inhibitors help treat hair loss and prostate issues but may cause sexual side effects.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.